BPC-157 is primarily researched for its role in tissue repair, gastrointestinal healing, and musculoskeletal recovery in preclinical animal studies
Clinical Applications in Inflammatory Conditions Inflammatory Bowel Disease (IBD) Preclinical studies have demonstrated BPC-157's efficacy in experimental models of IBD, including both ulcerative colitis and Crohn's disease
In fact, the study concluded that all of the rats treated showed significant improvement in being able to move their tails after paralysis
The results demonstrated that BPC157 significantly upregulated the expression of the PDGF subunit B (PDGFB), FGF2, FGF receptor (FGFR), and EGF receptor (EGFR), without altering the secretion of the VEGF and EGF (Fig
When diagnosed and treated early, you can reverse most effects within a few months